Publications
5530 Results
- Journal / Conference
- ASCO 5:104(#402)
- Year
- 1986
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8308
Combination cisplatin and dichloromethotrexate in advancedbladder cancer: A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- ASCO 5:169(#661)
- Year
- 1986
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8367
Sequential chemotherapy and neutron irradiation (XRT) for limitednon small cell lung cancer (NSCLC): A Southwest Oncology Group study.
- Journal / Conference
- ASCO 5:181(#711)
- Year
- 1986
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8460
Cyclophosphamide, vincristine, platinum and etoposide (COPE)and radiation therapy for extensive small cell lung cancer (SCLC). ASoutwest Oncology Group study.
- Journal / Conference
- Oncology Issues 4(2):8-12
- Year
- 1986
The present status and future outlook of clinical research in the community
- Journal / Conference
- Urology Internationalis 41(4):254-259
- Year
- 1986
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8216/38
A trial of bacillus calmette-guerin versus adriamycin in superficial bladder cancer: A South-west Oncology Group study.
- Journal / Conference
- Journal of Cancer Progam Management, ACCC 1(1):19-22
- Year
- 1986
The SWOG experience with CCOP's
- Journal / Conference
- Academic Press Inc., Harcourt Brace Jovanovitch New York. Chap ii, pp. 137-153
- Year
- 1985
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-440, SWOG-774/775, SWOG-7406, SWOG-7518
Bleomycin in combination with MOPP in the management of advanced Hodgkin's disease: A Southwest Oncology Group experience. In: Bleomycin Chemotherapy, BI Sikic, M Rozencweig, SK Carter, eds.
- Journal / Conference
- Arch Intern Med 145:1006-1012
- Year
- 1985
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-7315/16
High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
- Journal / Conference
- Martinus Nijhoff Publishing, pp 343-341
- Year
- 1985
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7518
Chemotherapy alone versus combined modality treatment for stage III Hodgkin's disease (H'sd): A five-year follow-up of Southwest Oncology Group (SWOG) study #7518. Proceedings of the Second International Conference on Malignant Lymphoma, Chap VI - Hodgkins Disease: Experimental and Therapeutic Approaches.
- Journal / Conference
- JCO 3(7):964-968
- Year
- 1985
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-7628